Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
10.66
-0.44 (-3.96%)
Oct 16, 2026, 4:00 PM EDT - Market closed
Keros Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Maintains $18 | Buy | Maintains | $18 | +68.86% | Sep 2, 2026 |
| Bank of America Securities | Bank of America Securities | Hold Reiterates $20 → $17 | Hold | Reiterates | $20 → $17 | +59.47% | Aug 11, 2026 |
| Wedbush | Wedbush | Hold Maintains $16 | Hold | Maintains | $16 | +50.09% | Aug 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $20 | Buy | Reiterates | $20 | +87.62% | Aug 4, 2026 |
| William Blair | William Blair | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Aug 4, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $30 → $23 | Buy | Maintains | $30 → $23 | +115.76% | Aug 4, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |